ICH M12 Step 4: what's new in DDI studies regulation?
ICH published the final version of the M12 guideline, marking a pivotal step towards standardizing drug-drug interaction (DDI) studies.
top of page
Preci LLC
- May 10
Solving Microsome Pooling Challenges for Better Reproducibility
Microsome technology significantly enhances our understanding of drug metabolism, playing a crucial role in the development of...
Preci LLC
- Apr 12
Preci and Biopredic International partner for higher performance of suspended pooled hepatocytes with extended longevity and large-scale availability
License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME...
Preci LLC
- Jan 19
What are the different types of human hepatocytes assays and how are they used?
The safety of newly developed lead compounds is often prioritized over efficacy. Additionally, the efficacy of a drug in a living...
Preci LLC
- Jul 28, 2023
Extracellular Matrix - from EHS mouse to human tissue
For three decades already researchers globally use Matrigel and similar products as a solid support for tissues in for in vitro modeling...
Preci LLC
- Jul 28, 2023
ADME-Tox assays with Biopredic International
Preci and Biopredic International announced the partnership intended to deliver high-quality hepatocytes assays to researchers. Biopredic...
Preci LLC
- Jul 28, 2023
Human-derived cell models - road to predictive drug activity assays
Simple reliable assays render drug that are clinically useful. We all recall the succesful attempt of James Cook to discover the drug...
© 2024
bottom of page